Literature DB >> 19183714

Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.

Diana R Mager1, Simon Ling, Eve A Roberts.   

Abstract

BACKGROUND: Childhood obesity is currently approaching epidemic proportions worldwide. Various chronic diseases are associated with obesity, but nonalcoholic fatty liver disease (NAFLD) has received little attention from paediatricians. AIM: To examine anthropometric and metabolic variables relevant to NAFLD disease mechanism and severity.
METHODS: A retrospective review of 53 consecutive paediatric patients clinically diagnosed with NAFLD was performed between 1997 and 2004. Variables studied included ethnicity, body mass index, acanthosis nigricans, aspartate aminotransferase and alanine amino-transferase levels, and fasting levels of glucose, insulin and lipids. Insulin resistance was quantified by validated models (the homeostasis model of insulin resistance [HOMA-IR] and the quantitative insulin-sensitivity check index [QUICKI]).
RESULTS: The cohort was comprised of 34 boys and 19 girls; there was a 2:1 male predominance. The mean age of the children was 13.5 years (median 14.2 years; range 5.6 to 18.9 years), and 13 were 11 years of age or younger. Forty-five per cent were Caucasian, 30% Asian and 21% Hispanic. Thirty-eight children (72%) were classified as obese and 11 children (21%) were classified as overweight, with a mean ideal body weight percentage of 150.9+/-4.2 (range 67% to 226%) and a BMI Z score of 1.9+/-0.1 (range -1.2 to 3.2). Hyperinsulinemia was present in 35 children (66%). Insulin resistance (HOMA-IR 9.8+/-2.6, abnormal if greater than 3) was associated with increased plasma triglyceride (P=0.03) and total cholesterol (P=0.04) levels. These parameters were significant irrespective of alanine aminotransferase or aspartate aminotransferase levels.
CONCLUSIONS: Hyperlipidemia with hyperinsulinemia and insulin resistance in overweight and obese children with fatty liver may be important signs of liver dysfunction in childhood NAFLD, irrespective of serum aminotransferases. In overweight or obese children with hyperlipidemia or insulin resistance, evaluation for NAFLD is warranted.

Entities:  

Keywords:  Children; Hyperinsulinemia; Insulin resistance; Non-alcoholic fatty liver disease; Obesity; Overweight

Year:  2008        PMID: 19183714      PMCID: PMC2528731     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  55 in total

1.  Definitions and pathophysiology of the metabolic syndrome in obese children and adolescents.

Authors:  S Caprio
Journal:  Int J Obes (Lond)       Date:  2005-09       Impact factor: 5.095

Review 2.  Diagnostic accuracy of the BMI for age in paediatrics.

Authors:  J J Reilly
Journal:  Int J Obes (Lond)       Date:  2006-04       Impact factor: 5.095

3.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

4.  Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention.

Authors:  Jirí Hrebícek; Vladimír Janout; Jana Malincíková; Dagmar Horáková; Ludek Cízek
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

5.  Prevalence of overweight and obesity in Australian children and adolescents: reassessment of 1985 and 1995 data against new standard international definitions.

Authors:  A M Magarey; L A Daniels; T J Boulton
Journal:  Med J Aust       Date:  2001-06-04       Impact factor: 7.738

6.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

7.  Steatohepatitis in obese children: a cause of chronic liver dysfunction.

Authors:  J R Moran; F K Ghishan; S A Halter; H L Greene
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

Review 8.  Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

Authors:  G M Reaven
Journal:  Panminerva Med       Date:  2005-12       Impact factor: 5.197

9.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06

10.  Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference.

Authors:  H David McCarthy; Sandra M Ellis; Tim J Cole
Journal:  BMJ       Date:  2003-03-22
View more
  4 in total

1.  Metabolic predictors for early identification of fatty liver using doppler and B-mode ultrasonography in overweight and obese adolescents.

Authors:  Mine Ozkol; Betül Ersoy; Erhun Kasirga; Fatma Taneli; Işil Esen Bostanci; Bayram Ozhan
Journal:  Eur J Pediatr       Date:  2010-05-25       Impact factor: 3.183

2.  Biochemical, anthropometric and body composition indicators as predictors of hepatic steatosis in obese adolescents.

Authors:  Amanda Oliva Gobato; Ana Carolina J Vasques; Roberto Massao Yamada; Mariana Porto Zambon; Antonio de Azevedo Barros-Filho; Gabriel Hessel
Journal:  Rev Paul Pediatr       Date:  2014-06

3.  Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.

Authors:  Peige Song; Jinyue Yu; Manli Wang; Xinlei Chang; Jiawen Wang; Lin An
Journal:  Int J Environ Res Public Health       Date:  2017-04-27       Impact factor: 3.390

4.  [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].

Authors:  Ana Paula Grotti Clemente; Bárbara Dal Molin Netto; Joana Pereira de Carvalho-Ferreira; Raquel Munhoz da Silveira Campos; Aline de Piano Ganen; Lian Tock; Marco Túlio de Mello; Ana Raimunda Dâmaso
Journal:  Rev Paul Pediatr       Date:  2015-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.